Adam Havey - EVP, Emergent Biosolutions Inc

As of March 3, 2021


Adam Havey Net Worth

  • Net worth is estimated to be at least $15.77M
  • Owns at least 38,190 units of Emergent Biosolutions Inc stock
  • Sold an estimated value of $14.55M in the last 10 years at Emergent Biosolutions Inc

Adam Havey Compensation at Emergent Biosolutions Inc in 2020

  • Earned a $546,507 salary
  • Rewarded $700,047 in stock value and options
  • Received a total compensation of $2,175,528

Adam Havey Trading

  • Largest purchase of shares was 37,279 units , worth over $1.52M on March 3, 2021
  • Largest sale of shares was 37,279 units , worth over $3.7M on March 3, 2021
  • In total has made about 42 transactions over 10 years
  • Usually trades in March, with the busiest year in 2017
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Adam Havey Mailing Address

  • Mailing address is 2273 Research Blvd Suite 400 Rockville MD 20853 MD

Emergent Biosolutions Inc Executive Compensation

Name
Year
Salary
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Fuad El-Hibri 2020 $1,192,202 $1,200,046 $815,051 - $6,185 $3,213,484
Fuad El-Hibri 2019 $1,131,577 $1,099,949 $773,813 - $4,723 $3,010,062
Fuad El-Hibri 2018 $1,047,031 $957,456 $957,481 - $8,250 $2,970,218
Robert Kramer 2020 $893,860 $2,050,007 $1,392,416 $1,225,020 $8,675 $5,569,978
Robert Kramer 2019 $678,021 $1,439,958 $1,012,999 $557,108 $5,735 $3,693,821
Robert Kramer 2018 $549,047 $649,930 $649,980 $538,807 $8,983 $2,396,747
Richard Lindahl 2020 $549,390 $749,998 $509,425 $462,012 $10,475 $2,281,300
Richard Lindahl 2019 $514,826 $619,984 $436,154 $297,429 $9,104 $1,877,497
Richard Lindahl 2018 $365,393 $557,438 $351,101 $330,007 $8,514 $1,612,453
Adam Havey 2020 $546,507 $700,047 $475,413 $445,204 $8,357 $2,175,528
Adam Havey 2019 $484,120 $619,984 $436,154 $279,579 $25,530 $1,845,367
Adam Havey 2018 $480,728 $499,974 $359,784 $310,212 $8,383 $1,659,081
Atul Saran 2020 $528,803 $700,047 $475,413 $445,204 $9,565 $2,159,032
Atul Saran 2019 $503,774 $619,984 $436,154 $293,567 $9,500 $1,862,979
Atul Saran 2018 $488,730 $527,475 $379,572 $293,567 $8,683 $1,698,027
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1367644/000136764421000061/ebsi2021asmproxystatement.htm

Emergent Biosolutions Inc Insider Trading

  • The most recent transaction was 3,139 units sold on May 27, 2021 by Kathryn Zoon worth over $177.29K
  • In the last 15 years, insiders at Emergent Biosolutions Inc sold an estimated value of $236.88M and bought an estimated value of $38.53M
  • The most active traders are Fuad Elhibri, Chairman,  Daniel Abdunnabi, CEO,  and Robert Kramer, President and CEO
  • Insider trading is most common in May, with the busiest year in 2007

Emergent BioSolutions Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1